Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» U.S. court invalidates patent on Bristol hepatitis B drug
U.S. court invalidates patent on Bristol hepatitis B drug
U.S. court invalidates patent on Bristol hepatitis B drug
Submitted by
admin
on February 12, 2013 - 10:46am
Source:
Reuters
News Tags:
Bristol-Myers Squibb
hepatitis B
Baraclude
patents
Headline:
U.S. court invalidates patent on Bristol hepatitis B drug
Do Not Allow Advertisers to Use My Personal information
